Angiotensin-II receptor antagonist losartan dose-dependently improves the left ventricular remodelling in patients with congestive heart failure

Journal of Clinical and Basic Cardiology

Volumn 5, Issue 1, 2002, Pages 83-86

  Berezin, A E ^a,b  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

^b Box 6323 ^*  (Ukraine)

Author keywords

Congestive heart failure; Losartan; Myocardial remodelling; Treatment

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ADULT; AGED; ARTICLE; B SCAN; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOSE RESPONSE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; STRESS; TREATMENT PLANNING;

EID: 0036232507     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Neuroendocrine activation in heart failure
2. Tissue renin-angiotensin system in myocardial hypertrophy and failure
3. The treatment of heart failure
4. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure; rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II
5. ABC of heart failure. Heart failure in general practice
6. Recommendations for quantification of the left ventricle by two-dimensional echocardiography
7. Canadian consensus recommendations for measurement and reporting of diastolic dysfunction by echocardiography
8. The acute and chronic effects of losartan in heart failure
9. Angiotensin II receptor antagonist in heart failure: Rationale and design of the Evaluation of Losartan in the Elderly (ELITE) trail
10. Prevention of worsening heart failure: Future focus
11. 1-receptor blockers in hypertension and heart failure: Clinical experience and future directions
12. Effects of candesartan, enalapril or their combination on exercise capacity, ventricular function, clinical deterioration and quality of life in heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD)
13. 1 receptor blockade on survival, systemic and coronary haemodynamics and cardiac remodelling in postischemic heart failure in rats
14. Comparative haemodynamic and renin-angiotensin system responses to the first dose of losartan or captopril in elderly patients with CHF